The aim of this study was to evaluate the osteogenic behavior of two chemically similar bioactive glass products (Biogran®and Perioglas®) implanted in critical bone defects in rat calvaria. Thirty-six transfixed bone defects of 8 mm diameter were made surgically in adult male Wistar rats. The animals were distributed equally into three groups: Biogran (GI), Perioglas (GII) and without implant material (control; GIII). The morphology and composition of both bioactive glasses were analyzed by scanning electron microscopy and energy-dispersive spectrometry. Tissue specimens were analyzed at the biological time points of 15, 30 and 60 days by optical microscopy and morphometry, demonstrating biocompatibility for the tested materials with moderate chronic inflammation involving their particles. Bone neoformation resulted only as a reparative reaction to an intentionally produced defect and was limited to the defect’s edges. No statistically significant differences among the groups were observed. At the scar interstice, abundant deposits of collagenous fibers enveloping the particles were noted. The present results indicated that the bioactive glasses, under the experimental conditions analyzed, did not show osteogenic behavior.

Keywords:
Bioactive glass, Bone regeneration, Biomaterials, Aloplastic graft
1.
Anderson, S.I. (2001) The Effect of Silicon, Silica and Silicates on the Osteoblast in vitro; PhD thesis, University of Nottingham.
2.
Aza, P.N., Z.B. Luklinska, C. Santos, F. Guitian, S. Aza (2003) Mechanism of bone-like formation on a bioactive implant in vivo. Biomaterials 24: 1437–1445.
3.
Bergman, S.A., L.J. Litkowski (1995) Bone in-fill of non-healing calvarial defects using particulate Bioglass® and autogenous bone. Bioceramics 8: 17–21.
4.
Bosch, C., B. Melsen, K. Vargervik (1998) Importance of the critical-size bone defect in testing bone-regenerating materials. J Craniofac Surg 9: 310–316.
5.
Bosetti, M., L. Zanardi, L. Hench, M. Cannas (2002) Type I collagen production by osteoblast-like cells cultured in contact with different bioactive glasses. J Biomed Mater Res A 64: 189–195.
6.
Busa, W.B., R. Nuccitelli (1984) Metabolic regulation via intracellular pH. Am J Physiol 246: 409–438.
7.
Cancian, D.C.J., E. Hochuli-Vieira, R.A.C. Marcantonio, E. Marcantonio Jr. (1999) Use of Biogran and calcite in bone defects: histologic study in monkeys (Cebus apella). Int J Oral Maxillofac Implants 14: 859–864.
8.
Carano, R.A.D., E.H. Filvaroff (2003) Angiogenesis and bone repair. Drug Discov Today 8: 980–989.
9.
Chan, C., I. Thompson, P. Robinson, J. Wilson, L. Hench (2002) Evaluation of Bioglass/dextran composite as a bone graft substitute. Int J Oral Maxillofac Surg 31: 73–77.
10.
Chesmel, K.D., J. Branger, H. Wertheim, N. Scarborough (1998) Healing response to various forms of human demineralized bone matrix in athymic rat cranial defects. J Oral Maxillofac Surg 56: 857–863.
11.
Ducheyne, P. (1998) Stimulation of biological function with bioactive glass. MRS Bull 23: 43–49.
12.
Frame, J.W. (1980) A convenient animal model for testing bone substitute materials. J Oral Surg 38: 176–180.
13.
Fujishiro, Y., L.L. Hench (1997) Quantitative rates of in vivo bone generation for Bioglass® and hydroxyapatite particles as bone graft substitute. J Mater Sci Mater Med 8: 649–652.
14.
Furusawa, T., K. Mizunuma (1997) Osteoconductive properties and efficacy of resorbable bioactive glass as a bone-grafting material. Implant Dent 6: 93–101.
15.
Gough, J.E., J.R. Jones, L.L. Hench (2004) Nodule formation and mineralization of human primary osteoblasts cultured on a porous bioactive glass scaffold. Biomaterials 25: 2039–2046.
16.
Hench, L.L. (1991) Bioceramics: from concept to clinic. J Am Ceram Soc 74: 1487–1510.
17.
Hench, L.L., I.D. Xynos, J.M. Polak (2004) Bioactive glasses for in situ tissue regeneration. J Biomater Sci Polym Ed 15: 543–562.
18.
Miguel, F.B., A.K.M.V. Cardoso, A.A. Barbosa Jr., E. Marcantonio Jr., G. Goissis, F.P. Rosa (2006) Morphological assessment of the behavior of three-dimensional anionic collagen matrices in bone regeneration in rats. J Biomed Mater Res B Appl Biomater 78: 334–339.
19.
Misch, C.E., F.D. Dietsh (1993) Bone-grafting materials in implant dentistry. Implant Dent 2: 158–167.
20.
Murphy, W.L., C.A. Simmons, D. Kaigler, D.J. Mooney (2004) Bone regeneration via a mineral substrate and induced angiogenesis. J Dent Res 83: 204–210.
21.
Norton, M.R., J. Wilson (2002) Dental implants placed in extraction sites implanted with bioactive glass: human histology and clinical outcome. Int J Oral Maxillofac Implants 17: 249–257.
22.
Oonishi, H., L.L. Hench, J. Wilson, F. Sugihara, E. Tsuji, S. Kushitani, H. Iwaki (1999) Comparative bone growth behavior in granules of bioceramic materials of various sizes. J Biomed Mater Res 44: 31–43.
23.
Oonishi, H., S. Kushitani, E. Yasukawa, H. Iwaki, L.L. Hench, J. Wilson, E. Tsuji, T. Sugihara (1997) Particulate bioglass compared with hydroxyapatite as a bone graft substitute. Clin Orthop Relat Res 334: 316–325.
24.
Piattelli, A., A. Scarano, M. Piattelli, F. Coraggio, S. Matarasso (2000) Bone regeneration using bioglass: an experimental study in rabbit tibia. J Oral Implant 26: 257–261.
25.
Rosa, F.P., E. Marcantonio Jr., M.A. Pizzaia, M.A.C. Gabrielle, R.C.C. Lia, A.O. Boschi, L.A. Santos (1998) Avaliação histológica de três diferentes tipos de hidroxiapatitas implantadas em arco zigomático de rato. Rev Odontol UNESP 27: 495–508.
26.
Schepers, E., L. Barbier, P. Ducheyne (1998) Implant placement enhanced by bioactive glass particles of narrow size range. Int J Oral Maxillofac Implants 13: 655–665.
27.
Schepers, E., M. De Clercq, P. Ducheyne, R. Kempeneers (1991) Bioactive glass particulate material as a filler for bone lesions. J Oral Rehabil 18: 439–452.
28.
Schepers, E.J., P. Ducheyne (1997) Bioactive glass particles of narrow size range for the treatment of oral bone defects: a 1–24 month experiment with several materials and particle sizes and size ranges. J Oral Rehabil 24: 171–181.
29.
Schepers, E., P. Ducheyne, L. Barbier, S. Schepers (1993) Bioactive glass particles of narrow size range: a new material for the repair of bone defects. Implant Dent 2: 151–156.
30.
Schmid, J., B. Wallkamm, C.H. Hammerle, S. Gogolewski, N.P. Lang (1997) The significance of angiogenesis in guide bone regeneration. A case report of a rabbit experiment. Clin Oral Implants Res 8: 244–248.
31.
Schmitz, J.P., J.O. Höllinger (1986) The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res 225: 299–308.
32.
Silver, I.A, J. Deas, M. Erecinska (2001) Interactions of bioactive glasses with osteoblasts in vitro: effects of 45S5 Bioglass, and 58S and 77S bioactive glasses on metabolism, intracellular ion concentrations and cell viability. Biomaterials 22: 175–185.
33.
Takagi, K., M. Urist (1982) The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects. Ann Surg 196: 100–109.
34.
Vrouwenvelder, W.C.A., C.G. Groot, K. Groot (1993) Histological and biochemical evaluation of osteoblast cultured on bioactive glass, hydroxylapatite, titanium alloy and stainless steel. J Biomed Mater Res 27: 465–475.
35.
Wheeler, D.L., K.E. Stokes, R.G. Hoellrich, D.L. Chamberland, S.W. Mcloughlin (1998) Effect of bioactive glass particle size on osseous regeneration of cancellous defects. J Biomed Mater Res 41: 527–533.
36.
Wheeler, D.L., K.E. Stokes, H.M. Park, J.O. Höllinger (1997) Evaluation of particulate Bioglass in a rabbit radius ostectomy model. J Biomed Mater Res 35: 249–254.
37.
Xynos, I., A.J. Edgar, L.D.K. Butter, L.L. Hench, J.M. Polak (2001) Gene expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res 55: 151–157.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.